John Lesnick

2.2k citations

12 papers · 846 indexed · h-index 9

Impact in

Urology top 2%
- Urinary Bladder and Prostate Research
Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in ⓘ

Cellular and Molecular Neuroscience 6
- Neuroscience and Neuropharmacology Research 3
- Neurotransmitter Receptor Influence on Behavior 3
Molecular Biology 11
- Receptor Mechanisms and Signaling 8
- Ion channel regulation and function 1

Co-authors: Jeffrey R. Jasper (7 shared papers)Anthony Ford (4 shared papers)David E. Clarke (4 shared papers)David J. Chang (3 shared papers)Donald V. Daniels (3 shared papers)Joel R. Gever (2 shared papers)Richard M. Eglen (4 shared papers)David R. Blue (3 shared papers)
Journals: British Journal of Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)FEBS Letters (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
Partner nations: United States Switzerland

In The Last Decade

John Lesnick

12 papers receiving 799 citations

Peers

Countries citing papers authored by John Lesnick

Since Specialization

Citations

This map shows the geographic impact of John Lesnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lesnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lesnick more than expected).

Fields of papers citing papers by John Lesnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lesnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lesnick. The network helps show where John Lesnick may publish in the future.

Co-authors

The 25 scholars most cited alongside John Lesnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Lesnick Line = papers co-authored together John Lesnick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Pharmacological pleiotropism of the human recombinant α_1A‐adrenoceptor: implications for α₁‐adrenoceptor classification British Journal of Pharmacology ·Anthony Ford, Donald V. Daniels, David J. Chang, Joel R. Gever, Jeffrey R. Jasper, John Lesnick, David E. Clarke	1997	200
2	RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Molecular Pharmacology ·Anthony Ford, Nicolas F. Arredondo, David R. Blue, D W Bonhaus, Jeffrey Jasper, M. Shannon Kava, John Lesnick, J. R. PFISTER, Ing-Shih Shieh, Rachel L. Vimont, T.J. Williams, J E McNeal, T A Stamey, David E. Clarke	1996	180
3	Ligand Efficacy and Potency at Recombinant α2 Adrenergic Receptors Biochemical Pharmacology ·Jeffrey R. Jasper, John Lesnick, Leon Chang, Susan S Yamanishi, Thomas K. H. Chang, Sherry Hsu, David A. Daunt, Douglas W. Bonhaus, Richard M. Eglen	1998	144
4	Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR ACS Medicinal Chemistry Letters ·Timothy P. Heffron, Chudi Ndubaku, Laurent Salphati, Bruno Alicke, Jonathan Cheong, Joy Drobnick, Kyle A. Edgar, Stephen E. Gould, Leslie B. Lee, John Lesnick, Cristina Lewis, Jim Nonomiya, Jodie Pang, Emile G. Plise, Steve Sideris, Jeffrey J. Wallin, Lan Wang, Xiaolin Zhang, Alan G. Olivero	2016	76
5	Molecular cloning, genomic characterization and expression of novel human α_1A‐adrenoceptor isoforms FEBS Letters ·David J. Chang, Thomas K. H. Chang, Susan S Yamanishi, Felix H. Salazar, Alan Kosaka, Reena Khare, Sunil Bhakta, Jeffrey R. Jasper, Ing-Shih Shieh, John Lesnick, Anthony Ford, Donald V. Daniels, Richard M. Eglen, David E. Clarke, Chinh Bach, Hardy Chan	1998	73
6	Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies European Journal of Pharmacology ·Donald V. Daniels, Joel R. Gever, Jeffrey R. Jasper, M. Shannon Kava, John Lesnick, Trena D. Meloy, George Stepan, Timothy J. Williams, David E. Clarke, David J. Chang, Anthony Ford	1999	68
7	Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild‐type and D79N α_2A‐adrenoceptor transgenic mice British Journal of Pharmacology ·Q‐M Zhu, John Lesnick, Jeffrey R. Jasper, Sara MacLennan, Michael P. Dillon, Richard M. Eglen, David R. Blue	1999	63
8	Imidazoline-Binding Domains on Monoamine Oxidase B and Subpopulations of Enzyme Journal of Pharmacology and Experimental Therapeutics ·Rita Raddatz, SANDRA L. SAVIC, Venkatesalu Bakthavachalam, John Lesnick, Jeffrey R. Jasper, C R McGrath, Angelo Parini, Stephen M. Lanier	2000	25
9	Miniaturization of High-Throughput Epigenetic Methyltransferase Assays with Acoustic Liquid Handling SLAS TECHNOLOGY ·Bonnie Edwards, John Lesnick, Jing Wang, Nga Tsing Tang, Carl Peters	2015	9
10	Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase Bioorganic & Medicinal Chemistry Letters ·Steven T. Staben, Nicole Blaquière, Vickie Tsui, Aleksandr Kolesnikov, Steven Do, Erin K. Bradley, Jenna Dotson, Richard Goldsmith, Timothy P. Heffron, John Lesnick, Cristina Lewis, Jeremy Murray, Jim Nonomiya, Alan G. Olivero, Jodie Pang, Lionel Rougé, Laurent Salphati, BinQing Wei, Christian Wiesmann, Ping Wu	2012	5
11	α_2A‐Adrenoceptors, Not I₁‐Imidazoline Receptors, Mediate the Hypotensive Effects of Rilmenidine and Moxonidine in Conscious Mice: In Vivo and In Vitro Studies Annals of the New York Academy of Sciences ·Qianqian Zhu, John Lesnick, Jeffrey R. Jasper, Sara MacLennan, Michael P. Dillon, Richard M. Eglen, David R. Blue	1999	2
12	Whole Genome Sequencing of Microbial Communities for Scaling Microbiome and Metagenomic Studies Journal of Biomolecular Techniques JBT ·Jefferson Lai, Scott Hutto, John Lesnick	2019	1

About John Lesnick

John Lesnick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Urology, Biochemistry and Animal Science and Zoology, having authored 12 papers that have together received 846 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Glioma Diagnosis and Treatment (1 paper), Ion channel regulation and function (1 paper), Caching and Content Delivery (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Urology (197 citations), Cellular and Molecular Neuroscience (330 citations), Endocrinology, Diabetes and Metabolism (185 citations), Behavioral Neuroscience (29 citations) and Molecular Biology (530 citations). John Lesnick has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Jeffrey R. Jasper, Anthony Ford, David E. Clarke, David J. Chang, Donald V. Daniels, Joel R. Gever, Richard M. Eglen, David R. Blue, Thomas K. H. Chang and Leon Chang. Their work appears in journals such as British Journal of Pharmacology, Journal of Pharmacology and Experimental Therapeutics, ACS Medicinal Chemistry Letters, FEBS Letters and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact